In this article, we present new evidence from medical registry data that further supports Tavneos liver drug injury lawsuits. We have been investigating possible Tavneos liver injury cases involving Tavneos drug-induced liver injury (DILI) and Tavneos-related vanishing bile duct syndrome (VBDS) during 2026, and will continue to do so. New … [Read more...]
Tavneos Vanishing Bile Duct Syndrome Warning Addition to Drug Label
In late April 2026, Amgen announced a Tavneos vanishing bile duct syndrome warning addition to the Tavneos Prescribing Information document, or drug label, was submitted to the FDA for their consideration. This Amgen action came just two days after the FDA announced it was considering a Tavneos drug recall for reasons having to do with new drug … [Read more...]
Tavneos Vasculitis Drug Safety: Deaths and Liver Injuries Legal Cases
Following the March 2026 Tavneos vasculitis drug safety alert from the FDA, we are investigating possibly related deaths and liver injuries legal cases to be filed against the drug company Amgen on behalf of patients using Tavneos who developed serious liver side effects or the families of those patients who died. Tavneos Vasculitis Drug … [Read more...]